id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2016-D-4317-0007,FDA,FDA-2016-D-4317,Final Guidance for Industry Compounding and Repackaging of Radiopharmaceuticals by Outsourcing Facilities,Other,Guidance,2018-09-27T04:00:00Z,2018,9,2018-09-27T04:00:00Z,,2024-11-12T06:18:27Z,,1,0,090000648377aea9
FDA-2016-D-4317-0006,FDA,FDA-2016-D-4317,Compounding and Repackaging of Radiopharmaceuticals by Outsourcing Facilities; Guidance for Industry; Availability,Notice,Notice of Availability,2018-09-26T04:00:00Z,2018,9,2018-09-26T04:00:00Z,,2018-09-27T13:56:19Z,2018-20901,0,0,0900006483774632
FDA-2016-D-4317-0002,FDA,FDA-2016-D-4317,Draft Guidance for Compounding and Repackaging of Radiopharmaceuticals By Outsourcing Facilities Guidance for Industry,Other,Guidance,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,2017-02-28T04:59:59Z,2019-08-21T15:09:05Z,,0,0,090000648243ddb2
FDA-2016-D-4317-0001,FDA,FDA-2016-D-4317,Compounding and Repackaging of Radiopharmaceuticals by Outsourcing Facilities; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2016-12-29T05:00:00Z,2016,12,2016-12-29T05:00:00Z,,2016-12-29T14:53:06Z,2016-31512,0,0,090000648243d4ab